Hydroxychloroquine + azithromycin had a significant effect on COVID-19 infected patients length of stay in the hospital.
Tag: SARS-CoV-2
To have covered up the knowledge for four decades that viruses could potentially be treated by antimicrobials required extensive effort
Source: The Lancet Summary Background Hydroxychloroquine is one of several agents being evaluated in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We aimed to examine whether patients with rheumatological conditions receiving chronic hydroxychloroquine therapy are at less risk of developing SARS-CoV-2 infection thanthose not receiving hydroxychloroquine. Methods This retrospective cohort study […]
In this trial, no deaths occurred related to hydroxychloroquine, and serious side effects were rare.
An Urgent Call to Depoliticize Medicine in the COVID-19 Pandemic
Source: American Institute for Economic Research The following letter has made an impact on public health authorities not only in Belgium but around the world. The text could pertain to any case in which states locked down their citizens rather than allow people freedom and permit medical professionals to bear the primary job of disease mitigation. So […]
Ms Lobb, is about two-thirds of the way through her four month trial and there have been no side effects so far. She also hasn’t contracted COVID-19.
Informed doctors know hydroxychloroquine works, and can save lives – and 5,000 doctors in Philippines have just spoken out.
“Alternative opinions were ignored or ridiculed. We have not seen open debates in the media, where different views could be expressed.”
medical service for remdesivir is weak and that access to reimbursement is not justified to treat the most severe forms of the disease.
“The government has re-purposed the drug HCQ for treatment of mild (but high-risk cases) and for moderate cases.”
Source: Pan African Medical Journal Mary Eyram Ashinyo1,&, Vida Duti2, Stephen Dajaan Dubik3, Kingsley Ebenezer Amegah4, Selorm Kutsoati5, Ebenezer Oduro-Mensah6, Peter Puplampu7, Martha Gyansa-Lutterodt8, Delese Mimi Darko9, Kwame Ohene Buabeng10, Anthony Ashinyo11, Anthony Adofo Ofosu12, Nyonuku Akosua Baddoo13, Samuel Kaba Akoriyea1, Francis Ofei14, Patrick Kuma-Aboagye15 1Institutional Care Division, Ghana Health Service Headquarters, Accra, Ghana, 2IRC-Ghana, Cantoments-Accra, […]
HCQ or CQ should be used efficiently alone or in combination with AZ to optimize the management of asymptomatic and mild cases of COVID-19.
It is worth giving Ivermectin triple therapy as a treatment for COVID-19 patients because it’s a harmless medication & it’s shown a great deal of promise.
‘’Treatment with an oral combination of hydroxychloroquine, azithromycin and zinc may REPRESENT THE BEST CURRENT THERAPEUTIC OPTION in relation to its antiviral and immunomodulatory effects’’.
Professor Moussa Seydi confirmed that the use of hydroxychloroquine with the antibiotic azithromycin is effective for early stage cases.
We made COVID-19 protocols, and they have hydroxychloroquine being used as a prophylaxis for frontline workers.
Source: Steven Phillips, MD Indian Medical Association endorses prophylactic use of HCQ for the police department to prevent COVID19. The Bengal State Branch recommended to the West Bengal Police Director General: As your members are also front line workers, we suggest your members without having any contraindications to take hydroxychloroquine tablets as prophylactic measures, if […]
The official death rate from COVID-19 is a shocking 73 percent lower, on average, than in areas where HCQ is prohibited.
It could be possible that this treatment only works when used early and in particular patient groups with similar characteristics as in the present study.
Hydroxychloroquine and ivermectin have been available for ages, but as COVID-19 is new, a patient with coronavirus may not get treated even if they ask.
By the time there was a study, two years later, 17,000 people died who probably would have survived. This makes a total of 190,000 dead patients for Fauci.
We believe this study is fatally flawed: “Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis”.
There seems to be a trend towards lower mortality among patients who received treatment with the combination of hydroxychloroquine and azithromycin than among those who did not
This is an Indian study about the use of hydroxychloroquine for infection prevention against COVID-19. This study has not released any official data yet.
Asian countries overall have fared better in controlling Covid-19, with lower mortality which is due to demographics and use of HCQ.
Such a violation has never occurred before for any medication ever, which points to how extremely politicised Hydroxychloroquine has become.
No more as the listed studies below total 7x more patients. They consistently demonstrate that HCQ saves lives. The UK missed the boat, likely due to overdosing, and misled the world.
Patients were given up to 6-12 times the maximum safe HCQ dosage. I mean the inanity of designating a drug as a poison because it was a vital medicine!
Harris says hydroxychloroquine could be used as a preventive measure, and it’s not dangerous as evidenced by its wide use for prevention of malaria.
No matter what opinions there are, the public ought to be treated like adults, allowed to to see it and decide for themselves.
Hydroxychloroquine may interfere with viral infection or cytokine storms observed in Covid-19 with severe acute respiratory distress syndrome.
How many people need to die before safe and viable treatments, such as hydroxychloroquine, are made widely available?
“We realise that chloroquine can be used in the early stage of the COVID-19 infection as prophylactic treatment. Science does not lie.”
The study concluded that hydroxychloroquine can be effective when given early after a COVID-19 diagnosis, and there was no negative side effects.
My dose is only two grams, far less than the doses most studies use. There’s a toxic level of HCQ and if you get above that there will be side effects.
HCQ and AZI are safe in haemodialysis patients at these doses, and HCQ concentrations were not correlated with side effects.
In this study, SARS-CoV-2 infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization.
Our study, including a large sample of patients hospitalized with COVID-19 in Italy, shows HCQ use had a 30% reduction of overall in-hospital mortality.
HCQ use was associated with a 30% lower risk of death in COVID-19 hospitalized patients. Our data doesn’t discourage use of HCQ in inpatients with COVID-19.